Hypertrophic Osteoarthropathy: Causes, Symptoms, and Treatment

Hypertrophic osteoarthropathy (HOA)—formerly called hypertrophic pulmonary osteoarthropathy—is a syndrome characterized by periosteal new bone formation (clubbing), joint pain, and synovial effusion. It is distinct from primary osteoarthritis.

Classification

• Primary (Hereditary): Rare, autosomal dominant (pachydermoperiostosis). Presents in adolescence with clubbing, thickened skin, and joint involvement without underlying disease.
• Secondary (Acquired): Far more common. Associated with intrathoracic malignancies (especially non-small cell lung cancer), cyanotic congenital heart disease, infective endocarditis, GI malignancies, and chronic suppurative lung diseases (bronchiectasis, lung abscess, cystic fibrosis).

Pathophysiology

Mechanism involves vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) released from neoplastic or hypoxic tissues, stimulating periosteal proliferation and vascular hyperplasia at distal extremities.

Clinical Features

• Digital clubbing: Loss of Lovibond angle, increased nail bed fluctuation, Schamroth's sign positive.
• Arthralgia/arthritis: Symmetric, large joints (knees, ankles, wrists, elbows). Synovial fluid is non-inflammatory.
• Periostitis: Tenderness over long bones (tibia, radius, ulna); radiographic "parallel tracking" of periosteal reaction.
• Skin changes: Hyperhidrosis, seborrhea, thickened skin (primary form).

Diagnosis

Clinical criteria + imaging (X-ray, bone scan, MRI) + search for underlying cause (chest CT, echocardiogram, tumor markers).

Treatment

Treat the underlying condition (e.g., tumor resection). Symptomatic relief with NSAIDs, bisphosphonates, or octreotide. Primary HOA: symptomatic management; genetic counseling.

Prognosis

Secondary HOA often resolves if underlying cause is treated early. Primary HOA is chronic but non-fatal.